NCT04598932

Brief Summary

The objective of this study is to measure the Brillouin biomechanical properties in keratoconic corneas and characterize biomechanical alterations that occur after corneal procedures that inherently strengthen or weaken the cornea by evaluating the change in Brillouin metrics before and after treatments.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Jun 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jun 2021Dec 2026

First Submitted

Initial submission to the registry

May 19, 2020

Completed
5 months until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 17, 2026

Status Verified

September 1, 2025

Enrollment Period

5.1 years

First QC Date

May 19, 2020

Last Update Submit

February 12, 2026

Conditions

Keywords

BrillouinKeratoconusKeratoconus, UnstableCorneal Cross LinkingCXLLASIKPRKSMILE

Outcome Measures

Primary Outcomes (1)

  • Change in Brillouin Metrics

    Brillouin metrics to be evaluated include localized Mean Brillouin modulus measure across the cornea and at each depth of the corneal stroma

    Difference between baseline and 3 months after intervention

Study Arms (6)

1: Normal Controls

Patients with normal corneas without any prior surgery to serve as the control group

Device: Brillouin microscopy

2 Keratoconus

Patients with various stages of keratoconus

Device: Brillouin microscopy

3: LASIK

Patients with normal corneas who are undergoing laser in situ keratomileusis (LASIK)

Device: Brillouin microscopy

Group 4: PRK

Patients with normal corneas who are undergoing photorefractive keratectomy (PRK)

Device: Brillouin microscopy

5: SMILE

Patients with normal corneas who are undergoing small incision lenticular extraction (SMILE)

Device: Brillouin microscopy

6: CXL

Patients with keratoconus who are undergoing corneal cross-linking (CXL)

Device: Brillouin microscopy

Interventions

The Brillouin clinical instrument is comprised of three parts: a human interface, a laser-scanning confocal microscope, and an etalon-based spectrometer. The human interface is a modified ophthalmic slit-lamp instrument with chin support and headrest. The light source is a single longitudinal mode CW laser at 780 nm. A polarizing beam splitter and quarter-wave plate assembly sends the laser beam to the human interface. To focus light into the eye, a long-working distance microscope objective is used. Brillouin scattered light from the eye is collected with a single-mode optical fiber. For spectral analysis, a two-stage VIPA-etalon spectrometer configured with the cross-axis cascade principle and the spectrum is measured on a EM-CCD camera.

1: Normal Controls2 Keratoconus3: LASIK5: SMILE6: CXLGroup 4: PRK

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Group 1: Patients with normal corneas Group 2: Patients with keratoconus Group 3: Patients with normal corneas undergoing LASIK Group 4: Patients with normal corneas undergoing PRK Group 5: Patients with normal corneas undergoing SMILE Group 6: Patients with keratoconus undergoing CXL

You may qualify if:

  • patients aged 18-60 with keratoconus
  • patients aged 18-60 with normal corneas,
  • patients aged 18-60 undergoing refractive surgery (LASIK, PRK, SMILE)
  • patients aged 18-60 with keratoconus undergoing CXL

You may not qualify if:

  • outside age range
  • history of previous ocular surgeries
  • unable to cooperate for the Brillouin microscopic examination
  • unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Cole Eye Institute

Cleveland, Ohio, 44195, United States

Location

Related Publications (7)

  • Zhang H, Roozbahani M, Piccinini AL, Golan O, Hafezi F, Scarcelli G, Randleman JB. Depth-Dependent Reduction of Biomechanical Efficacy of Contact Lens-Assisted Corneal Cross-linking Analyzed by Brillouin Microscopy. J Refract Surg. 2019 Nov 1;35(11):721-728. doi: 10.3928/1081597X-20191004-01.

    PMID: 31710374BACKGROUND
  • Webb JN, Langille E, Hafezi F, Randleman JB, Scarcelli G. Biomechanical Impact of Localized Corneal Cross-linking Beyond the Irradiated Treatment Area. J Refract Surg. 2019 Apr 1;35(4):253-260. doi: 10.3928/1081597X-20190304-01.

    PMID: 30984983BACKGROUND
  • Randleman JB, Su JP, Scarcelli G. Biomechanical Changes After LASIK Flap Creation Combined With Rapid Cross-Linking Measured With Brillouin Microscopy. J Refract Surg. 2017 Jun 1;33(6):408-414. doi: 10.3928/1081597X-20170421-01.

    PMID: 28586502BACKGROUND
  • Scarcelli G, Pineda R, Yun SH. Brillouin optical microscopy for corneal biomechanics. Invest Ophthalmol Vis Sci. 2012 Jan 20;53(1):185-90. doi: 10.1167/iovs.11-8281.

  • Scarcelli G, Kling S, Quijano E, Pineda R, Marcos S, Yun SH. Brillouin microscopy of collagen crosslinking: noncontact depth-dependent analysis of corneal elastic modulus. Invest Ophthalmol Vis Sci. 2013 Feb 19;54(2):1418-25. doi: 10.1167/iovs.12-11387.

  • Scarcelli G, Besner S, Pineda R, Yun SH. Biomechanical characterization of keratoconus corneas ex vivo with Brillouin microscopy. Invest Ophthalmol Vis Sci. 2014 Jun 17;55(7):4490-5. doi: 10.1167/iovs.14-14450.

  • Scarcelli G, Besner S, Pineda R, Kalout P, Yun SH. In vivo biomechanical mapping of normal and keratoconus corneas. JAMA Ophthalmol. 2015 Apr;133(4):480-2. doi: 10.1001/jamaophthalmol.2014.5641. No abstract available.

MeSH Terms

Conditions

Keratoconus

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician

Study Record Dates

First Submitted

May 19, 2020

First Posted

October 22, 2020

Study Start

June 1, 2021

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 17, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

there is no plan to share data

Locations